Johnson & Johnson said on Wednesday Canada gave full approval to its single-shot COVID-19 vaccine for people aged 18 years and older, making it the first full approval for the vaccine globally. The vaccine was previously authorized by the country under an interim order. Canada, which is reporting 2,563 infections on average each day and has administered at least 60,101,058 doses…
Health Canada authorized the use of the Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age. This is the first COVID-19 vaccine authorized in Canada for use in this age group and marks a major milestone in Canada’s fight against COVID-19. Health Canada received an application from Pfizer-BioNTech to expand the indication of Comirnaty on October 18, 2021. The…
The Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Social Sciences and Humanities Research Council of Canada (SSHRC) have harmonized their policy to align more clearly with the Treasury Board Policy on Transfer Payments (PTP) with regard to the eligibility and funding of research projects or programs submitted by applicants…
Alliance Missions grants will provide $100,000 to $500,000 per year for two years, to initiate research collaborations between Canada’s academic researchers and partners from private, public and/or not-for-profit partner organization(s). These grants will cover 100% of the eligible costs of research for a two-year period. The proposed projects should catalyze the development of partnerships between university researchers and partner organizations;…
BioTalent Canada today announced the kickoff of a $1.15M research study titled Building Resiliency and Sustainability for the Bio-economy to Withstand Disruption. The project, funded by the Future Skills Centre, which wraps up in September 2022, will leverage lessons learned from the pandemic to ensure long-term sustainability within Canada’s bio-economy. Because of the pandemic, Canadians are realizing the crucial work being done…
Canada’s bio-economy is facing a severe labour shortage, with demand far exceeding supply as soon as 2024 according to a new, unprecedented labour market study released today by BioTalent Canada. The national data and analysis suggests the growing bio-economy sector will need as many as 65,000 additional workers by 2029 to meet demand, and current forecasts show the talent pipeline…
Canada holds a leadership position on a global scale in terms of the way we understand cancer. We also excel in the development of new anti-cancer therapies, especially therapies that use the immune system. This is called immunotherapy. Canadian researchers play a very important role in the development of immunotherapy research. This is a very important area in anti-cancer therapies…
The Canada Biomedical Research Fund (CBRF) and Biosciences Research Infrastructure Fund (BRIF) are essential components of the Strategy, each designed to strengthen research systems and the talent pipeline. The CBRF supports high-risk, applied research, training and talent development, as part of a suite of foundational investments to establish a resilient, robust domestic biomanufacturing sector in Canada. This fund contributes to the pipeline…
Canadians look to the 44th Parliament to apply lessons learned from COVID-19 to protect current and future generations. This includes building healthcare systems equipped for both exceptional and everyday circumstances. To be successful, we believe the government needs to partner with the entire health ecosystem in a way that leverages multiple strengths. Life science stakeholders, in particular, can play a…
An industry association says it’s reaching out to biotechnology companies across Canada to develop a strategy to contend with a labour shortage problem in the sector which has accelerated during the COVID-19 pandemic. “It’s a highly competitive space. You’re trying to attract talent from around the world to Canada. You’re also trying to retain what you do have here because…